SCHEMBL25580953

SCHEMBL25580953

c1ccc(-c2ccc(-c3ccccc3N(c3cccc(-c4cccc(-c5ccccc5)c4-c4ccccc4-c4ccccc4)c3)c3ccc4oc5ccccc5c4c3)cc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ PLA2G2A P14555 3/20 0.33
▸ PLA2G4A P47712 3/20 0.33
▸ HSP90AA1 P07900 1/20 0.32
▸ HSP90AB1 P08238 1/20 0.32
▸ PLA2G10 O15496 1/20 0.32
▸ AHR P35869 1/20 0.31
▸ LMNA P02545 1/20 0.30
▸ TNKS O95271 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25580842 0.98 NPC1 (0.35) ALOX5KDM4EMEN1NPC1ALDH1A1
SCHEMBL25580676 0.95 NPC1 (0.35) ALOX5KDM4EMEN1NPC1ALDH1A1
SCHEMBL25580538 0.94 NPC1 (0.35) ALOX5KDM4EMEN1NPC1ALDH1A1
SCHEMBL25580960 0.93 ALOX5 (0.35) ALOX5KDM4EMEN1ALDH1A1MAPT
SCHEMBL25580274 0.92 KDM4E (0.34) ALOX5KDM4EMEN1NPC1ALDH1A1
SCHEMBL25580310 0.92 KDM4E (0.34) ALOX5KDM4EMEN1NPC1ALDH1A1
SCHEMBL25580194 0.92 KDM4E (0.34) ALOX5KDM4EMEN1NPC1ALDH1A1
SCHEMBL25580812 0.92 ALOX5 (0.37) ALOX5KDM4EMEN1NPC1ALDH1A1
SCHEMBL25580910 0.92 ALOX5 (0.37) ALOX5KDM4EMEN1NPC1ALDH1A1
SCHEMBL25578818 0.91 NPC1 (0.35) ALOX5KDM4EMEN1NPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ESR1, L1CAM, ESR2 ALOX5 1615/4885KDM4E 2752/4885MEN1 101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback